High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsInvestigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospitalDetection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium sppPrevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago.In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains.Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.Multiple-locus VNTR Analyses of Methicillin-resistant Staphylococcus aureus from Jamaica.Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in immunocompromised cancer patients undergoing chemotherapy in Pakistan.Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?
P2860
Q24646677-B6FAEBD9-288F-4C16-A2B8-37B310F5FC0FQ24810927-14EA0148-E24F-470E-A1C9-81186098FD76Q33613735-648AD76F-9DC7-4E9E-B7B9-49C16E2FC8D7Q34141027-5DA5829A-A8B5-4DD9-A18D-9250D61E6B42Q34983312-769FF792-2AC0-4EC7-AAA0-C2A5365A18B1Q35023234-DB1537B4-0203-4F3F-B615-4B42D94E58B8Q36099449-006D4F5C-F125-442C-B008-AA32731F51F5Q36779557-8BEF852D-E09C-4849-A15C-8182B1D60E48Q37717901-731357B1-62D1-45F5-9DDD-BBD788803E63Q40961288-12F2BC7D-FE2C-4792-99BE-D9D03B23E35BQ41066970-F6686CE7-7604-474F-975B-7AC204783F17Q46083250-2E200835-9FAE-4D8A-BB4E-24F8059EB046Q54392892-0536B6B3-13B3-4E84-9B6D-7A49CB2C077F
P2860
High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
High percentage of methicillin ...... ycopeptides in The Netherlands
@ast
High percentage of methicillin ...... ycopeptides in The Netherlands
@en
type
label
High percentage of methicillin ...... ycopeptides in The Netherlands
@ast
High percentage of methicillin ...... ycopeptides in The Netherlands
@en
prefLabel
High percentage of methicillin ...... ycopeptides in The Netherlands
@ast
High percentage of methicillin ...... ycopeptides in The Netherlands
@en
P2093
P2860
P1476
High percentage of methicillin ...... ycopeptides in The Netherlands
@en
P2093
Annemarie Van 't Veen
Anton Buiting
Arjanne Van Griethuysen
Timothy Walsh
P2860
P304
P356
10.1128/JCM.41.6.2487-2491.2003
P407
P577
2003-06-01T00:00:00Z